T1International

From WikiMD.com Medical Encyclopedia

T1International logo

T1International is a global advocacy organization focused on addressing the challenges faced by individuals living with Type 1 diabetes. The organization is dedicated to ensuring access to affordable and equitable care for all people with Type 1 diabetes worldwide.

Mission and Vision[edit | edit source]

T1International's mission is to advocate for people with Type 1 diabetes by supporting local communities and influencing global policy. The organization envisions a world where everyone with Type 1 diabetes has access to the medicine and care they need to survive and thrive.

History[edit | edit source]

T1International was founded in 2013 by Elizabeth Rowley, who recognized the need for a global movement to address the disparities in diabetes care. The organization has since grown to include a network of advocates and volunteers from around the world.

Activities[edit | edit source]

T1International engages in a variety of activities to support its mission:

Advocacy[edit | edit source]

The organization works to influence policy at both the national and international levels. It collaborates with governments, healthcare providers, and other stakeholders to promote policies that improve access to insulin and diabetes care.

Community Support[edit | edit source]

T1International supports local advocacy groups and provides resources to empower individuals to advocate for their own needs. The organization offers training and tools to help communities organize and campaign effectively.

Education[edit | edit source]

The organization provides educational resources to raise awareness about Type 1 diabetes and the challenges faced by those living with the condition. T1International aims to educate the public, healthcare professionals, and policymakers about the importance of access to insulin and diabetes care.

Global Impact[edit | edit source]

T1International has made significant strides in raising awareness about the global insulin crisis. The organization has been instrumental in highlighting the high cost of insulin and the impact of this on individuals with Type 1 diabetes, particularly in low- and middle-income countries.

Challenges[edit | edit source]

Despite its successes, T1International faces several challenges, including:

  • The high cost of insulin and diabetes supplies.
  • Disparities in healthcare access across different regions.
  • The need for increased awareness and understanding of Type 1 diabetes.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD